Development and multicenter evaluation of the N latex CDT direct immunonephelometric assay for serum carbohydrate-deficient transferrin.

BACKGROUND Carbohydrate-deficient transferrin (CDT) is a promising biomarker of alcohol abuse. We describe the development and multicenter evaluation of N Latex CDT (Dade Behring), an automated, particle-enhanced, homogeneous immunonephelometric assay for directly determining CDT. METHODS N Latex CDT uses a monoclonal antibody that recognizes the structure of transferrin glycoforms lacking 1 or 2 complete N-glycans [i.e., disialo-, monosialo-, and asialotransferrins (CDT glycoforms)] in combination with a simultaneous assay for total transferrin. The Dade Behring BN II and BN ProSpec systems automatically calculate the CDT value as a percentage of total transferrin (%CDT). No preanalytical sample treatment is used. RESULTS Total imprecision values for serum pools containing 1.8%-8.7% CDT were 3.4%-10.4% (mean, 6.8%). The mean (SD) %CDT for 561 serum samples from healthy control individuals was 1.76% (0.27%; range, 1.01%-2.85%). No marked sex or age differences were noted. The 97.5th percentile was at 2.35%. Transferrin genetic variants did not interfere with measurements. High transferrin concentrations did not falsely increase %CDT values, but increased %CDT values were noted for some samples with transferrin concentrations <1.1 g/L. N Latex CDT results correlated with those of a commercial CDT immunoassay involving column separation (r(2) = 0.862) and an HPLC candidate reference method (r(2) = 0.978). CONCLUSION N Latex CDT is the first direct immunoassay for quantifying %CDT in serum. The specificity of N Latex CDT for identifying alcohol abuse may be higher than for immunoassays that use column separation, because transferrin genetic variants do not interfere with measurements.

[1]  J. Weill,et al.  Serum desialotransferrin in the detection of alcohol abuse. Definition of a Tf index. , 1987, Drug and alcohol dependence.

[2]  S. Borg,et al.  A modified method for the assay of carbohydrate-deficient transferrin (CDT) in serum. , 1991, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[3]  H. Neels,et al.  Determination of carbohydrate-deficient transferrin using capillary zone electrophoresis. , 2001, Clinical chemistry.

[4]  J. Jaeken,et al.  Congenital disorders of glycosylation (CDG): It's all in it! , 2003, Journal of Inherited Metabolic Disease.

[5]  A. Helander,et al.  Study of Axis-Shield new %CDT immunoassay for quantification of carbohydrate-deficient transferrin (CDT) in serum. , 2001, Alcohol and alcoholism.

[6]  J. Whitfield,et al.  Diagnostic tests for alcohol consumption. , 1995, Alcohol and alcoholism.

[7]  L. Dibbelt,et al.  Is there an analytical or diagnostic advantage from including trisialo transferrin into the fraction of carbohydrate-deficient transferrin? Lessons from a comparison of two commercial turbidimetric immunoassays with the carbohydrate-deficient transferrin determination by high-performance liquid chro , 2000, Clinical biochemistry.

[8]  R. Stout,et al.  Analysis of carbohydrate deficient transferrin by capillary zone electrophoresis , 1997, Electrophoresis.

[9]  A. Lundblad,et al.  Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. , 1995, Biochemical and biophysical research communications.

[10]  J. Jaeken,et al.  Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. , 2004, Clinical chemistry.

[11]  S. Ohlson,et al.  HPLC analysis of carbohydrate deficient transferrin isoforms isolated by the Axis-Shield %CDT method. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[12]  A. Haines,et al.  Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. , 1988, BMJ.

[13]  E. Gotschlich,et al.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. , 1984, Analytical biochemistry.

[14]  J. Landers,et al.  Capillary electrophoresis‐based separation of transferrin sialoforms in patients with carbohydrate‐deficient glycoprotein syndrome , 1997, Electrophoresis.

[15]  J. V. Dijk,et al.  The biology of transferrin. , 1990 .

[16]  J. Pagès,et al.  Dose-effect relation between daily ethanol intake in the range 0-70 grams and %CDT value: validation of a cut-off value. , 2005, Alcohol and alcoholism.

[17]  A. Helander,et al.  Carbohydrate-deficient transferrin and gamma-glutamyl transferase levels during disulfiram therapy. , 1996, Alcoholism, clinical and experimental research.

[18]  K. Savage,et al.  Expression of glycosylated and nonglycosylated human transferrin in mammalian cells. Characterization of the recombinant proteins with comparison to three commercially available transferrins. , 1993, Biochemistry.

[19]  H. Freeze,et al.  Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms. , 2004, Clinical chemistry.

[20]  P. Sillanaukee,et al.  Comparison of different methods for detecting carbohydrate-deficient transferrin. , 1994, Alcoholism, clinical and experimental research.

[21]  J. Weill,et al.  Serum desialotransferrin in the detection of alcohol abuse. , 1987, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[22]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.

[23]  H. van Halbeek,et al.  N-glycosylation site mapping of human serotransferrin by serial lectin affinity chromatography, fast atom bombardment-mass spectrometry, and 1H nuclear magnetic resonance spectroscopy. , 1992, Analytical biochemistry.

[24]  J. Jeppsson,et al.  Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. , 1993, Clinical chemistry.

[25]  A. Helander,et al.  Comparison of HPLC and capillary electrophoresis for confirmatory testing of the alcohol misuse marker carbohydrate-deficient transferrin. , 2005, Clinical chemistry.

[26]  F. Tagliaro,et al.  Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  B. Hagberg,et al.  Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[28]  A. Helander,et al.  Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[29]  J. Jeppsson,et al.  Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. , 2001, Clinical chemistry.

[30]  L. Powell,et al.  Use of chromatofocusing to detect a transferrin variant in serum of alcoholic subjects. , 1985, Clinical chemistry.

[31]  H Stibler,et al.  Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. , 1991, Clinical chemistry.

[32]  A. Helander.  Biological markers in alcoholism. , 2003, Journal of neural transmission. Supplementum.

[33]  J. Delanghe,et al.  Transferrin polymorphism influences iron status in blacks. , 2000, Clinical chemistry.

[34]  H. G. van Eijk,et al.  Analysis of the Iron-Binding Sites of Transferrin by Isoelectric Focussing , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[35]  J. Jeppsson,et al.  Improved HPLC method for carbohydrate-deficient transferrin in serum. , 2003, Clinical chemistry.

[36]  A. Helander.  Absolute or relative measurement of carbohydrate-deficient transferrin in serum? Experiences with three immunological assays. , 1999, Clinical chemistry.

[37]  R. Ferrell,et al.  Human transferrin polymorphism. , 1987, Human heredity.

[38]  P. Bean,et al.  Allelic D variants of transferrin in evaluation of alcohol abuse: differential diagnosis by isoelectric focusing-immunoblotting-laser densitometry. , 1994, Clinical chemistry.

[39]  J. Michalski,et al.  The effects of ethanol on the glycosylation of human transferrin. , 2003, Glycobiology.

[40]  T. Arndt.  Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. , 2001, Clinical chemistry.